Emergency Department-based Cervical Cancer Screening Through Self-sampling

Advancing Cervical Cancer Screening Through Emergency Department-based Self-Sampling

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07345897

Enrollment

200

Registered

2026-01-16

Start date

2026-02-13

Completion date

2028-01-01

Last updated

2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer (Early Detection), Cervical Cancer Screening, HPV, HPV Associated Cancers, HPV Cancers

Keywords

HPV Screening, Cervical cancer screening, HPV, Cervical cancer

Brief summary

This project will compare the uptake of cervical cancer screening through ED HPV sampling among patients presenting to the ED.

Detailed description

This is a single-arm pilot trial with a prospectively enrolled sample. The participants who complete the screening survey and are determined to be adherent (n \ 600) will be notified that they appear to be adherent with current screening guidelines, and their participation ends at this point. These participants will be considered screen failures for study purposes. Women and transgender/non-binary individuals with a cervix, aged 30-65, will be recruited from a high-volume urban ED. Follow-up will occur at 150 days to determine CC screening activity, perceived and concrete barriers to care, and participant experiences with the intervention. Electronic Health Record (EHR) review will be conducted to corroborate participants' reports of screening activities and assess completion of clinic-based testing and clinical endpoints.

Interventions

DIAGNOSTIC_TESTCervical Cancer Screening

Subjects will perform self sampling for cervical cancer.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SCREENING

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

30 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Cisgender women and transgender/non-binary individuals with a cervix, * Age 30 - 65 years, and demonstrating decisional capacity to consent to participate with no known

Exclusion criteria

present.

Design outcomes

Primary

Measure	Time frame	Description
Uptake of cervical cancer screening from self-sampling in the ED	In about 150 days of enrollment	Number of subjects referred for additional screening who follow through with next steps in the screening process.

Countries

United States

Contacts

CONTACTResearch Administrator

peter_macdowell@urmc.rochester.edu585-274-1509

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 5, 2026